Respiratory Syncytial Virus
DATA SHEET
This data sheet is provided for information only.
Please contact our Customer Service for further information and pricing.
Respiratory syncytial virus (RSV)
Cat.# 8RSV79
Source:
MA 104 cells, inoculated with Respiratory syncytial virus, strain Long.
Purification:
Virus was grown on monolayer of MA cells. When the cultures showed pronounced c.p.e. virus containing medium was purified from cell fragments by low speed centrifugation (4000 rpm, 40 min). Virus was pelleted by high speed centrifugation at 18000 rpm for 2.5 hours in the SW27 rotor. The virus pellet was collected, diluted with STE buffer and layered over linear 30 to 60 % sucrose gradient prepared in STE buffer. The sample was recentrifuged at 25000 rpm in SW27 rotor for 2.5 h at + 4 oC, and then the virus band was collected, diluted with STE buffer and pelleted by centrifugation at 30000 rpm for 1.5 h at + 4 oC. The pellet of virus was collected and diluted in STE buffer.
Presentation:
STE, 0.1 % sodium azide (NaN3) and 0.005 % of thimerosal.
Inactivation:
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Analysis:
Purity > 90 %
Immunological activity:
Tested with anti-respiratory syncytial virus antibodies (Cat. # 3ReS21) in ELISA.
Storage:
- 20 oC
Material safety note:
Contains thimerosal (0.005 %) and sodium azide (0.1 %) as preservative. Although the amounts of thimerosal and sodium azide are very small, appropriate care must be taken when handling this product.
Additional product information:
Influenza and other Acute Respiratory Diseases (ARDs) TechNotes
References:
Search Respiratory Syncytial Virus references from PubMed
See other Respiratory Syncytial Virus references
Related products:
Cat# 3ReS21: Respiratory Syncytial Virus, Antibody
See other infectious and veterinary reagents
